Table 1.
Recovery from flecainide inhibition
τ1 | τ2 | τ3 | A1 | A2 | A3 | ||
---|---|---|---|---|---|---|---|
1 s prepulse | Control | 0.014 ± 0.002 | 0.40 ± 0.10 | — | 0.77 ± 0.03 | 0.23 ± 0.03 | — |
10 μm flecainide | 0.011 ± 0.002 | 0.18 ± 0.08 | 9.2 ± 5.4 | 0.71 ± 0.04 | 0.20 ± 0.04 | 0.09 ± 0.02 | |
10 s prepulse | Control | 0.016 ± 0.002 | 0.33 ± 0.06 | 3.1 ± 0.6 | 0.42 ± 0.02 | 0.36 ± 0.03 | 0.22 ± 0.04 |
10 μm flecainide | 0.014 ± 0.002 | 0.43 ± 0.08 | 8.7 ± 1.7 | 0.42 ± 0.02 | 0.35 ± 0.03 | 0.22 ± 0.03 | |
25 μm flecainide | 0.022 ± 0.007 | 0.35 ± 0.13 | 5.3 ± 1.9 | 0.38 ± 0.05 | 0.39 ± 0.06 | 0.23 ± 0.05 |
Recovery time constants (τ1–τ3) and relative amplitudes (A1–A3) obtained from curve fits of data shown in Fig. 2B.